| A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune … DT Le, DG Brockstedt, R Nir-Paz, J Hampl, S Mathur, J Nemunaitis, ... Clinical cancer research 18 (3), 858-868, 2012 | 394 | 2012 |
| IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells SZ Ben-Sasson, A Hogg, J Hu-Li, P Wingfield, X Chen, M Crank, ... Journal of Experimental Medicine 210 (3), 491-502, 2013 | 270 | 2013 |
| Prophage excision activates Listeria competence genes that promote phagosomal escape and virulence L Rabinovich, N Sigal, I Borovok, R Nir-Paz, AA Herskovits Cell 150 (4), 792-802, 2012 | 230 | 2012 |
| Factors Predicting Mortality of Patients With Lung Abscess* B Hirshberg, M Sklair-Levi, R Nir-Paz, L Ben-Sira, V Krivoruk, MR Kramer Chest 115 (3), 746-50, 1999 | 215 | 1999 |
| Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination R Nir-Paz, D Gelman, A Khouri, BM Sisson, J Fackler, S Alkalay-Oren, ... Clinical Infectious Diseases 69 (11), 2015-2018, 2019 | 206 | 2019 |
| BNT162b2 mRNA Covid-19 vaccine effectiveness among health care workers S Benenson, Y Oster, MJ Cohen, R Nir-Paz New England Journal of Medicine 384 (18), 1775-1777, 2021 | 184 | 2021 |
| Group G streptococcal bacteremia in Jerusalem R Cohen-Poradosu, J Jaffe, D Lavi, S Grisariu-Greenzaid, R Nir-Paz, ... Emerging infectious diseases 10 (8), 1455, 2004 | 145 | 2004 |
| Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010 D Averbuch, C Hidalgo-Grass, AE Moses, D Engelhard, R Nir-Paz Emrging Infectious Diseases 17 (6), 1079-1082, 2011 | 142 | 2011 |
| Deep Infection by Trichophyton rubrum in an Immunocompromised Patient R Nir-Paz, H Elinav, GE Pierard, D Walker, A Maly, M Shapiro, RC Barton, ... Journal of clinical microbiology 41 (11), 5298-5301, 2003 | 117 | 2003 |
| Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients H Klein, K Asseo, N Karni, Y Benjamini, R Nir-Paz, M Muszkat, S Israel, ... Clinical Microbiology and Infection 27 (5), 769-774, 2021 | 113* | 2021 |
| Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R Nir-Paz, A Michael-Gayego, M Ron, C Block Clinical microbiology and infection 12 (7), 685-688, 2006 | 108 | 2006 |
| Identification of Risk Factors for Infection in an Outbreak of Mycoplasma pneumoniae Respiratory Tract Disease E Klement, DF Talkington, O Wasserzug, R Kayouf, N Davidovitch, ... Clinical infectious diseases 43 (10), 1239-1245, 2006 | 105 | 2006 |
| Pregnancy-associated listeriosis: clinical characteristics and geospatial analysis of a 10-year period in Israel H Elinav, A Hershko-Klement, L Valinsky, J Jaffe, A Wiseman, H Shimon, ... Clinical Infectious Diseases 59 (7), 953-961, 2014 | 95 | 2014 |
| Imported melioidosis, Israel, 2008 A Cahn, B Koslowsky, R Nir-Paz, V Temper, N Hiller, A Karlinsky, I Gur, ... Emerging Infectious Diseases 15 (11), 1809, 2009 | 90* | 2009 |
| The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel S Pereyre, A Charron, C Hidalgo-Grass, A Touati, AE Moses, R Nir-Paz, ... PloS one 7 (6), e38585, 2012 | 84 | 2012 |
| Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists … L Papst, B Beović, C Pulcini, E Durante-Mangoni, J Rodríguez-Baño, ... Clinical Microbiology and Infection 24 (10), 1070-1076, 2018 | 75 | 2018 |
| Listeria monocytogenes multidrug resistance transporters and cyclic di-AMP, which contribute to type I interferon induction, play a role in cell wall stress M Kaplan Zeevi, NS Shafir, S Shaham, S Friedman, N Sigal, R Nir Paz, ... Journal of bacteriology 195 (23), 5250-5261, 2013 | 74 | 2013 |
| Clinical and Epidemiological Aspects of Infections Caused by Fusarium Species: a Collaborative Study from Israel R Nir-Paz, J Strahilevitz, M Shapiro, N Keller, A Goldschmied-Reouven, ... Journal of clinical microbiology 42 (8), 3456-3461, 2004 | 71 | 2004 |
| Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021 PMM Sauteur, ML Beeton, SA Uldum, N Bossuyt, M Vermeulen, K Loens, ... Eurosurveillance 27 (19), 2100746, 2022 | 61 | 2022 |
| Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions--Systematic review and meta-analysis I Linchevski, E Klement, R Nir-Paz Vaccine 27 (18), 2437-2446, 2009 | 61 | 2009 |
Ronen HazanLab 404, The Phage Therapy Lab and the Israeli Phage Therapy Center (IPTC), Institute of BiomedicalVerified email at ekmd.huji.ac.il
